Medicover AB Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Revenue	2,468	2,378	2,092
Revenue Growth	9.28%	13.69%	-
Cost of Revenue	1,891	1,827	1,644
Gross Profit	576.8	550.7	448.3
Selling, General & Admin	400.9	395	378
Total Operating Expenses	400.9	395	378
Operating Income	175.9	155.7	70.3
Interest Income	4.5	4.4	4.8
Interest Expense	-65.5	-64	-58.8
Other Non-Operating Income (Expense)	-5.8	2.3	3.8
Total Non-Operating Income (Expense)	-66.8	-57.3	-50.2
Pretax Income	109.1	98.4	20.1
Provision for Income Taxes	28.7	25.7	5.5
Net Income	35.9	72.7	14.6
Minority Interest in Earnings	-4.5	-4.8	-2.1
Net Income to Common	84.9	77.5	16.7
Net Income Growth	95.62%	364.07%	-
Shares Outstanding (Basic)	151	151	150
Shares Outstanding (Diluted)	151	151	150
Shares Change	0.61%	0.52%	-
EPS (Basic)	0.56	0.51	0.11
EPS (Diluted)	0.56	0.51	0.11
EPS Growth	93.77%	358.04%	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Free Cash Flow	345.2	343.7	261.9
Free Cash Flow Growth	22.72%	31.23%	-
Free Cash Flow Per Share	2.28	2.28	1.74
Dividends Per Share	0.200	0.200	0.150
Dividend Growth	33.33%	33.33%	-
Gross Margin	23.37%	23.16%	21.43%
Operating Margin	7.13%	6.55%	3.36%
Profit Margin	1.45%	3.06%	0.70%
FCF Margin	13.99%	14.45%	12.52%
EBITDA	396.3	371	284.9
EBITDA Margin	16.06%	15.60%	13.62%
EBIT	175.9	155.7	70.3
EBIT Margin	7.13%	6.55%	3.36%
Effective Tax Rate	26.31%	26.12%	27.36%